The role of nitric oxide (NO) synthesis in the cerebral hyperemic responses to hypercapnia and hypox ia was investigated in anesthetized rats. Regional CBF Abbreviations used: BS, brainstem; CE, cerebellum; CYR, cerebral vascular resistance; CX, cortex; EAA, excitatory amino acid; EDRF, endothelium derived relaxing factor; L-NAME, ni tro-L-arginine methyl ester; MANOY A, multivariate analysis of variance; NOS, nitric oxide synthase; PKC, protein kinase C; SC, subcortex.
(rCBF) measurements were obtained in the cortex (CX), subcortex (SC), brain stem (BS), and cerebellum (CE) us ing radiolabeled microspheres. The rCBF responses to either hypercapnia (P ac02 = 70-80 mm Hg) or hypoxia (P a02 = 40--4 5 mm Hg) were compared in rat groups stud ied in the presence and absence of NO synthase inhibition induced via the intravenous infusion of nitro-L-arginine methyl ester (L-NAME, 3 mg kg-1 min-I). Administra tion of L-NAME under normocapnic/normoxic conditions produced a 40-60% reduction in baseline rCBF values, indicating the presence of a NO "tone" in the cerebral vasculature. Infusion of L-NAME resulted in a substan tial attenuation, in all regions measured, of the rCBF in creases that normally accompany hypercapnia. In com paring saline-infused to L-NAME-infused rats, the per centage increases in rCBF (from normocapnic baseline values) were 351% versus 166% (CX), 446% versus 199% (SC), 443% versus 206% (BS), and 483% versus 174% (CE), respectively. The rCBF changes from baseline Vascular tissue, when exposed to certain physi ologic stimuli (e,g., activation of specific receptors, shear stress), can exhibit an endothelium dependent vasodilation in a wide range of struc tures, including the brain, via the synthesis and re lease of nitric oxide (NO) or nitrosothiol com pounds (Luscher and Vanhoutte, 1990; Myers et aI., 1990; Moncada et aI., 1991) . Furthermore, a continuous NO production appears to occur under resting conditions in many vascular beds, thereby imparting a vasodilatory "tone" (Gardiner et aI., 1990; Faraci, 1991; Persson et aI., 1991; Tanaka et aI., 1991; Pelligrino et aI., 1992) . NO is formed from the terminal guanidino nitrogen of L-arginine via the action of NO synthase (NOS) (e.g., Luscher and Vanhoutte, 1990) . In the brain, NOS is not only found in vascular endothelium but also in perivas cular nerves and astrocytes (Bredt et aI., 1990; Mur phy et aI., 1990; Garthwaite, 1991) . The constitutive NOS isoform found in the brain is dependent on the presence of calcium, calmodulin, NADPH, and tet rahydrobiopterin (Forstermann et aI., 1991; Mayer et aI., 1991) . Also, molecular oxygen is an essential substrate in the formation of NO (and citrulline) via NOS (Leone et aI., 1991) .
It is unclear whether enhanced NO release par ticipates in the CBF increases accompanying hyper capnia or hypoxia. There is evidence from in vitro experiments of an endothelium-dependent compo nent to the cerebral hyperemic response to hypoxia, suggestive of an enhanced NO activity (Pearce et al., 1989 (Pearce et al., , 1990 . On the other hand, one might sus pect a suppression of NO release during hypoxia, due to the O 2 requirement for NO synthesis (Leone et al. , 1991; Rengasamy and Johns, 1991) . Under hypercapnic conditions, recent reports indicated that in the presence of NOS inhibition, a blunting of the cortical CBF increase occurred, suggesting that NO release, at least in part, normally contributes to the CBF increase (Iadecola, 1992; Wang et al. , 1992) . However, evidence for this effect in other brain regions is lacking. In the present study, we evaluated the effects of NOS inhibition, via intra venous administration of nitro-L-arginine methyl es ter (L-NAME), on the regional CBF (rCBF) re sponses to hypoxia and hypercapnia. We recently demonstrated that intravenous L-NAME could completely block the profound cerebral hyperemic response accompanying administration of a musca rinic receptor agonist (Pelligrino et al., 1992) . Acti vation of muscarinic receptors is an accepted model for vascular relaxation mediated by endothelium derived NO (e.g., Luscher and Vanhoutte, 1990 ). Thus, the use of the L-NAME in this manner per mitted us to evaluate whether NO release is in volved in the rCBF increases induced by hypoxia or hypercapnia.
METHODS
The study protocol was approved by the Institutional Animal Care and Use Committee. Male Sprague-Dawley rats (350-450 g, n = 23) were used. For study, anesthesia was induced with halothane. The rats were then para lyzed with curare (1 mg kg-I i.v.), tracheotomized, and connected to a rodent respirator. The anesthesia used during the remaining surgery was 0.7% halothane170% NzO/30% Oz. Catheters were implanted in both femoral arteries and veins. An additional catheter was advanced into the left ventricle, following insertion into the right brachial artery. This catheter, employed in the injection of radiolabeled microspheres, was tapered over the final 2-3 cm from the tip so as to not occlude the right common carotid artery. Following surgery, the halothane was dis continued and wound sites were infiltrated with bupiva caine. The 70% NzO/30% 0z was maintained and an i.v. infusion of fentanyl was initiated (10 ILg kg -I loading dose) and continued throughout the study (25 ILg kg-I h -I ) . The experiments were started at -1 h post halothane. The arterial pressure pulse was recorded con tinuously during the study. The rectal temperature was servocontrolled at 3rc.
The experimental groups were as follows: hypercapnia (PaCOZ = 7�0 mm Hg), with (n = 7) and without (n = 4) i.v. L-NAME; hypoxia (PaOZ = 40-45 mm Hg), with (n = 5) and without (n = 4) i.v. L-NAME; and a 20 min i.v. L-NAME time control (n = 3). Hypercapnia was intro duced by adding COz to the inspiratory gas mixture (giv ing a concentration of 8%). For hypoxia, the inspiratory 0z concentration was reduced to 13% and Nz was added (at 17%). The L-NAME was infused at 50 ILl min-I to provide a dose of 3 mg kg -1 min -I. The rCBF was mea sured via radiolabeled micro spheres CS7Co, 113Sn, and 85Sr) in the cortex (CX), subcortex (SC), brainstem (BS), and cerebellum (CE). Details of the IT :lOdology were provided in an earlier publication fn . our laboratory (Pelligrino and Albrecht, 1991) .
In all experiments, a control rCBF measurement was made at 10 min following the initiation of an i. v. saline infusion (50 ILl min -I). In experiments where i. v. L-NAME was not given, the saline infusion was main tained and a second rCBF determination was made at 10 min of hypercapnia or hypoxia. Methoxamine was in fused (0.1-0.2 mg kg-I min -I) during hypoxia to prevent the mean arterial pressure (MAP) from falling below 90 mm Hg. The total dose of methoxamine given was similar when comparing experiments with and without L-NAME. Preliminary experiments confirmed that this dose of methoxamine had no influence on rCBF in a MAP range of 90-150 mm Hg. When L-NAME was used, a second rCBF measurement, following control, was obtained at 10 min of L-NAME (under normoxic/normocapnic condi tions). Hypercapnia or hypoxia was then introduced, while maintaining the L-NAME infusion, and a third rCBF determination was made 10 min later. In three rats, an L-NAME time control was performed, in which rCBF measurements were made (in normoxic/normocapnic rats) at 10 min of i. v. saline and at 10 and 20 min of i. v. L-NAME.
At the end of the experiment, the rats were killed with an overdose of halothane. The brains were then removed and dissected into the right and left CX, right and left SC (contains tissue primarily from the striatum, thalamus, and hippocampus), BS, and CEo Brain tissue samples were then weighed and placed (along with the blood with drawn during and following microsphere injections-see Hoffman et aI., 1983; Pelligrino and Albrecht, 1991) in a gamma counter (Nuclear Data, Inc.) . In this study, as in previous studies from our laboratory (Pelligrino and Al brecht, 1991; Pelligrino et aI., 1992) , we found no side-to side differences in rCBF in the CX or SC regardless of experimental manipulation. Thus, all rCBF values in these two regions are reported as the average of the two sides.
Partial pressures for arterial CO2 and 02' along with arterial pH, were measured using an IL 1303 blood gas/ pH analyzer. Cerebral vascular resistance (CVR) was es timated from the MAP divided by the rCBF. Statistical comparisons of rCBF values between experimental groups were made employing a multivariate analysis of variance (MANOV A, Systat). Analyses of results within experimental groups (e.g., comparisons to control or L-NAME alone) were performed using a repeated measures two-way ANOV A, along with a post hoc C ma trix multiple comparisons analysis (Systat). Statistical significance was taken at the p < 0.05 level.
RESULTS
The values for arterial Po 2 , Pco 2 , and pH and MAP in the four major experimental groups, ob- tained at the time of each rCBF measurement, are summarized in Table 1 . In both hypercapnic groups, as one would expect, inhalation of 8% CO 2 produced significant pH reductions from control, but equivalent elevations in Pe0 2 . In the rats given L-NAME, a slightly lower Pe0 2 value (vs. saline infused control) was measured at 10 min of infusion, immediately prior to induction of hypercapnia. At the same time, a significant 24 mm Hg increase in MAP from control was seen. The MAP increase was reversed during hypercapnia. Neither of the hypoxia-exposed groups showed variations in Pe0 2 at any time point during the experiments. Equal ar terial P0 2 values were measured in both groups fol lowing exposure to an inspired O 2 level of 13%. During hypoxia, the MAP values in these groups were similar but lower than control by 20-26 mm Hg. Administration of L-NAME prior to hypoxic induction, as observed in the corresponding hyper capnic group, produced a significant rise in MAP from control (LlMAP = 24 mm Hg). The arterial pH was significantly reduced from control during com bined L-NAME/hypoxia. In the absence of L-NAME, no fall in pH during hypoxia was ob served.
Hypercapnia and cerebral hemodynamics
In the absence of L-NAME, hypercapnia resulted in substantial increases in rCBF, from normocapnic levels, in all regions ( Fig. O. As a percentage of the normocapnic (i.e. , baseline) values (Table 2) , these increases ranged from 351 to 483% in the four re gions analyzed. The range of rCBF changes (LlrCBF) was 393-570 ml 100 g -1 min -1 ( Table 2) . Infusion of L-NAME, prior to induction of hyper capnia, resulted in significant reductions in rCBF, from saline-infused control levels, in all regions ( Fig. O. As a percentage of control, rCBF de creased to 62% (CX), 56% (SC), 55% (BS), and 53% (CE). Following the onset of hypercapnia, a se verely attenuated rCBF response, compared to non-L-NAME-infused rats, was observed. In fact, in only two regions (SC, BS) was the change from the normocapnic/L-NAME-infused level found to be statistically significant ( Fig. O . When expressed as a percentage of the normocapn�c/L-NAME flow values (baseline-Table 2), the rCBF values during hypercapnia/L-NAME were in the range of 166-206%, and when expressed as LlrCBF from base line, the values ranged from 45 to 72 ml 100 g-l min -1 (Table 2) . These rCBF changes were signif icantly reduced from the changes that normally oc cur in hypercapnia (see Table 2 . .
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FIG. 1. Regional cerebral blood flow (rCBF) values in the cortex (CX), subcortex (SC), brainstem (BS), and cerebellum (CE) during hypercapnia, with (left) and without (right) intra venous infusion of the NO synthase inhibitor, L-NAME. All rCBF values during hypercapnia + L-NAME were signifi cantly lower than those measured during hypercapnia alone. Additional information is provided in the text. All values are means ± SD. *p < 0.05 versus control (normocapnic saline infusion); #p < 0.05 versus L-NAME (normocapnic). would expect from the flow data, hypercapnia alone resulted in significant reductions in CVR in the dif ferent regions. With respect to control, infusion of L-NAME produced approximately twofold in creases in regional CVR values. When hypercapnia was then introduced, regional CVR values fell to levels not significantly different from control but, with the exception of the CX, significantly lower than values obtained during normocapnic L-NAME infusions. During hypercapnia, the regional CVR values were significantly (four-to fivefold) greater in rats infused with L-NAME compared to rats not given L-NAME.
Hypoxia and cerebral hemodynamics
When L-NAME was not infused, hypoxia re sulted in significant rCBF increases, from normoxic control, in all of the regions analyzed (Fig. 3) . These changes, expressed as a percentage of control, ranged from 156 to 210% (Table 2 ). The �rCBF val ues were in the range of 109 to 178 mll00 g-I min-I ( Table 2) . Infusion of L-NAME under normoxic conditions produced significant reductions in rCBF from control in all regions, similar to the changes represented in Fig. 1 (hypercapnia experiments) . Thus, rCBF decreased to 53% in the CX, 50% in the SC, 42% in the BS, and 49% in the CEo When hyp oxia was introduced, in spite of the lower baseline (i.e., normoxic L-NAME infusion) rCBF levels, the flows in all regions increased to values not statisti cally different from those measured during hypoxia without added L-NAME. When expressed as a per centage of the baseline values (Table 2) , the rCBF reached levels of 262-462%. With the exception of the CE, these values were significantly higher than those seen during hypoxia in the absence of L-NAME (see Table 2 and above). On the other hand, expressing the hypoxic flows as a change from baseline (6.rCBF) produced values (range = 150-180 ml 100 g-I min-I) during L-NAME infu sions that were larger but not significantly different from those measured in the absence of L-NAME (see Table 2 and above). Regional CVR values are presented in Fig. 4 . Hypoxia alone reduced CVR by �50% in the regions studied. Infusion of L-NAME See the text for more information. *p < 0.05 versus control (normoxic saline infusion); #p < 0.05 versus normoxic L-NAME infusion. produced a greater than or equal to twofold increase in regional CVR values. With hypoxia, these values fell by 70-80% to levels significantly lower than c ? ntrol in the SC, BS, and CE, but not significantly different from values obtained in the hypoxia alone group.
L-NAME and rCBF over time
Investigations of the effects of L-NAME on rCBF responses to hypercapnia or hypoxia used a 20 min L-NAME infusion (i.e. , 10 min of L-NAME alone followed by 10 min of L-NAME plus hypercapnia or hypoxia). It was, therefore, of some importance to ?etermine the influence on rCBF of L-NAME by itself over the time interval of 10-20 min. Figure 5 shows the rCBF values measured prior to introduc tion of L-NAME (10 min saline infusion) and at 10 and 20 min of an i.v. infusion of L-NAME. Consis tent with the data summarized in Figs. 1 and 3 , rCBF values in the four regions were reduced to 50-60% of control at 10 min. When going from 10 to 20 min, a slight further drop in rCBF (to 45-55% of control) was seen in three of the regions (CX, SC, and BS), but these changes were not statistically signi�cant. In these animals, arterial P0 2 and Peo 2 remamed constant and within normal limits throughout the experiments and MAP was in creased by 22 ± 5 mm Hg at 10 min and 19 ± 4 mm Hg at 20 min following L-NAME administration from an initial (saline infusion) value of 132 ± 7 mm Hg.
DISCUSSION
The results of this study indicate that NO synthe sis is critical to the cerebral vasodilatory response to hypercapnia. On the other hand, NO synthesis �n� release does not appear to contribute to hypox ta-mduced rCBF increases. In fact, inhibition of NOS prior to hypoxic induction may actually en- hance the hyperemic response, although the data are somewhat equivocal in this regard. The question of which mechanisms are responsi ble for hypercapnia-or hypoxia-induced increases in CBF was addressed in many reports, too numer ous to cite here (e.g. , see review by Busija and Heistad, 1984) . In spite of such wide attention in the literature, there remains a large measure of uncer tainty with regard to factors contributing to the va sodilatory process and factors that may modify or attenuate this process. Much of this diversity in ex perimental findings may be attributable to differ ences related to animal species, methodology (e.g. , in vivo vs. in vitro preparations), or animal age (i. e. , adult vs. neonate). In the rat, vasodilator pros tanoid production reportedly plays a large role in the hypercapnic response but no role in the hypoxic response (Sakabe and Siesj6, 1979) .
During hypercapnia, there appears to be little question that a decrease in brain extracellular pH is critical to the cerebral vasorelaxation response (e. g. , Lassen, 1968; Kontos et ai. , 1977) . Thus, any additional mechanisms one might propose (e.g. , prostanoid release and, in the present case, NO re lease) as participating in the cerebral hyperemic re sponse to hypercapnia must in some way require the presence of an increased H + ion concentration. The simplest explanation would be that increases in [H +] enhance NOS activity. In vitro activity of brain NOS was shown to be positively correlated with [H +], but only at pH values> 7. 0 (Heinzel et ai., 1992) . However, with relevance to hypercapnic states, no changes in NOS activity were seen in the 6.5-7.0 pH range. Perhaps increased H+ levels af fect intracellular Ca 2 + availability. Calcium is re quired for activation of the constitutive NOS iso form (Forstermann et ai., 1991) and in the activation of the enzyme initiating the prostanoid synthesis cascade, phospholipase A 2 (see Siesj6, 1981) . Inter-estingly, Cortey et ai. (1991) , in a preliminary study, reported that inhibition of protein kinase C (PKC) blocked the relaxation of pial arterioles induced by hypercapnia. These results, coupled with the fact that the principal isoforms of PKC are Ca 2 + depen dent (Nishizuka, 1988) , lend additional support to the idea that altered Ca 2 + availability may play a role in hypercapnic vasodilation. The present results of an attenuated CBF re sponse to hypercapnia following NOS inhibition confirms the findings of others (Iadecola, 1992; Wang et aI. , 1992) . These authors employed CBF measurement techniques in rats (laser-Doppler flowmetry or intracarotid xenon-133) that assess primarily cortical blood flow. Our findings demon strated that enhanced NO production is not only a component of the hypercapnic CBF response in the cortex, but also plays a major role in the hyperemic responses of subcortical and hindbrain structures as well.
We recently reported a normal CBF response to hypercapnia in chronically hyperglycemic diabetic rats (Pelligrino and Albrecht, 1991 ), a putative model of cerebral vascular endothelial damage (Moore et aI., 1985) to the extent that endothelium and receptor-dependent (e.g. muscarinic, puriner gic P 2 ) vasodilatory responses are profoundly im paired (Mayhan, 1989; Mayhan et at. , 1991; Pelli grino et aI., 1992) . These findings may suggest that hypercapnia induces NO synthesis in nonendothe lial structures and/or via a process different from the receptor-dependent mechanisms through which agonists like acetylcholine and ADP act.
The source of the L-NAME-sensitive NO forma tion in hypercapnia is not likely to be found in vas cular smooth muscle cells in that the intracellular Ca 2 + concentration needed to activate NOS would be inhibitory to guanylyl cyclase (Knowles et aI. , 1989) . This would block the increase in cyclic GMP essential to the vasorelaxation mechanism. Perivas cular astrocytes and neurons remain as potential sources of NO during hypercapnia (see the Intro duction), although the paucity of relevant informa tion in the literature renders any further discussion far too speCUlative. Vasodilator nerves to vascular smooth muscle do, however, represent a viable op tion. Okamura (1990, 1991) reported that the vasorelaxant response to transmural electrical stimulation in canine cerebral arterial strips, both endothelium intact and denuded, could be blocked in the presence of an NOS inhibitor, suggesting that nonendothelial NO plays a role in transmitting the vasodilatory signal. Interestingly, in an earlier study from the same laboratory, employing the same experimental preparation, it was found that hypercapnia-induced relaxation was unaffected by , endothelium removal (Toda et aI. , 1989) . In addition to indicating that the endothelium does not partici pate in the hypercapnic response, in support of our suggestion above, these authors also concluded that hypercapnia acts directly on the smooth muscle. In light of subsequent reports Okamura, 1990, 1991) , the possibility exists that hypercapnia may act by increasing NO production in the nona drenergic, noncholinergic vasodilator nerves asso ciated with this preparation, rather than via a direct action on smooth muscle cells. Recent findings sug gest that these nerves may arise from the spheno palatine but not the trigeminal ganglion (Nozaki et aI. , 1992 ; see also Sakas et aI. , 1989) . Present results showed that NOS inhibition did not diminish but rather may have augmented the rCBF increases associated with hypoxia. However, the conclusion of a heightened vasodilatory re sponse was dependent on the manner in which this was expressed (see the Results section). Neverthe less, these findings at a minimum speak against any role for NO/endothelium-dependent relaxation fac tor (EDRF) release in mediating hypoxia-induced cerebral vasodilation, as some investigators have suggested (Pearce et aI. , 1989 (Pearce et aI. , , 1990 Kozniewska et aI. , 1992) . In the study by Kozniewska et aI. (1992) , the absolute hypoxic CBF value was significantly lower in the group of rats treated with an NOS in hibitor, but the normoxic CBF was also reduced by NOS inhibition. This had the net effect that the rel ative hypoxia-induced increase in CBF was nearly the same in treated compared to untreated rats (2vs. 4.3-fold). Thus, any conclusion of a role for NO production in mediating the CBF response to hyp oxia would be questionable. The studies by Pearce et at. (1989 Pearce et at. ( , 1990 were conducted in vitro using large cerebral arteries (basilar and internal carotid) harvested from rabbits. Hypoxic vasodilation was attenuated following endothelial denudation or gua nylyl cyclase inhibition via methylene blue. Yet, when methylene blue was administered in vivo, the hypoxia-induced increase in CBF was unaffected (Pearce et aI., 1990) .
One might speculate that the failure to attenuate hypoxic CBF increases in vivo by methylene blue, and by NOS inhibition (present report), is related to an inability of hypoxia to induce NO release in the vicinity of smaller cerebral vessels. This is unlikely in that hypoxia is capable of inducing a profound vasodilatory response in brain microvessels (Morii et at. , 1987) , and there is evidence of an active va sodilatory mechanism in these small vessels that is sensitive to NOS inhibitors and methylene blue Marshall et aI., 1988; Busija et al., 1990; Rosenblum et al. , 1990; Faraci, 1991; Ha berl et al., 1991) . The possibility also exists that the factors mediating hypoxia-induced vasodilation in the brain are not the same in rabbits and rats. Fi nally, previous studies, employing adenosine recep tor antagonists (Hoffman et al. , 1984; Morii et al. , 1987) , demonstrated that the CBF increasel vasodilation accompanying moderate hypoxia (i.e. , P02 = 40-50 mm Hg) in rats was almost entirely mediated by adenosine release (see also Winn et al., 1981) . Thus, in moderate hypoxia in the rat, there appears to be little or no room remaining for an NO/EDRF component. With increasing hypoxic se verity, the relative role of adenosine decreases (Hoffman et al., 1984) , but other factors such as increased tissue H + , extracellular K + , or excitato ry amino acid (EAA) release could make up the difference (Busija and Heistad, 1984; Phillis and Walter, 1989; Hamilton et al. , 1992) . The last may be of some relevance to the present discussion in that EAAs can promote neuronal NO production and release (Garthwaite, 1991) 
The explanation for an enhanced CBF response following L-NAME administration may be related to the need for an adequate oxygen supply to sus tain NOS-mediated NO production (see Leone et al., 1991) . In support of this, Rengasamy and Johns (1991) reported that lowering the O 2 tension mark edly reduced NOS activity in brain homogenates, an effect that was readily reversed by normoxia. If one combines this O2 requirement for NOS activa tion with the presence of a NO-related vasodilatory "tone" in the brain, as the present and other studies have shown (Faraci, 1991; Tanaka et al. , 1991; Pel ligrino et al., 1992) , a hypoxia-induced attenuation of NO synthesis may act (in the absence of inhibi tors) to limit the hypoxia-associated cerebral hy peremic response. Then, if one inhibits NOS prior to hypoxia, thereby removing this "brake" on the CBF increase, one might see an augmented CBF response. We might add that this process, in rats, may be localized to large vessels, in that larger ar teries, rather than micro vessels , appear to be the site of basal NO/EDRF production (Faraci, 1991) . Consistent with this reasoning and in support of our findings, an enhancement of hypoxia-induced va sorelaxation in the face of EDRF antagonism was observed in sheep middle cerebral artery rings (Klaas and Wadsworth, 1989) . Nevertheless, there are experimental findings that appear to be incon sistent with the concept of hypoxia producing a di rect limitation on NO availability. In the study by Kozniewska et al. (1992) , the percentage increase from baseline CBF during hypoxia was similar in treated relative to untreated rats, whereas we found J Cereb Blood Flow Metab, Vol. 13, No.1, 1993 much greater relative increases in treated animals. This occurred despite the fact that the hypoxia was more severe in the Kozniewska et al. study (P a02 = 33 mm Hg). One explanation for this apparent in consistency can be derived from the observation that hypoxia can prolong the half-life of nitrosothi ols (Mulsch et al. , 1991) . Thus, the actual amount of NO/nitrosothiol available during hypoxia may be a function of two opposing processes-diminished synthesis but reduced inactivation, with the latter perhaps having a greater relative influence at a Pao2 of 33 mm Hg than at the current study level of -44 mm Hg. Another possibility is that more severe hypoxic challenges could lead to release of EAAs (see above). Therefore, one might speculate that NOS inhibition in more severe hypoxia may remove EAA-stimulated perivascular neuronal NO produc tion and also oppose the effects of diminished syn thesis, These issues are not going to be resolved here and need to be addressed in future investiga tions.
In summary, our study demonstrated that hyper capnia in rats induces an increase in CBF via a mechanism that is critically dependent on NO syn thesis. On the other hand, hypoxia increases CBF through a process that does not require NO. In fact, results suggested, although not conclusively, that hypoxia may suppress cerebral NO production.
